In recent years the aetiology of several neurometabolic disorders leading t
o childhood epilepsy and psychomotor retardation has been clarified. Treatm
ent approaches have been developed for some diseases. In some cases measura
ble metabolite abnormalities in fetal trophoblast or amniotic fluid and cel
ls or mutation analyses are now amenable to prenatal diagnosis. The followi
ng article gives an overview of some important "new diseases".